Over-the-counter sale of 14 steroid creams has been banned by the Health Ministry

The Indian health ministry made amendments to certain rules of the Drugs and Cosmetics Rules, 1945 and put 14 steroid-based creams and ointments under the Schedule H category.

This step has been taken to stop the indiscriminate sale of topical preparations containing steroids and antibiotics without the prescription.

Actually, this move is the result from the complaint made by the dermatologists where they clearly mentioned that many of their patients used steroid- based creams and ointments without medical supervision as many of the pharma companies were selling them freely over the counter.

The notice was released by the Health Ministry on this change in the March 2018. Drugs Technical Advisory Board (DTAB) also had submitted their consideration to Central Drugs Standards Control Organisation (CDSCO) regarding the ban on steroid based creams and ointments. Finally, Health Ministry made a decision with the consultation DTAB and CDSCO.

These rules are not applicable for ordinary face-cleansing and moisturizers. Some of the common creams that get banned are alclometasone, beclomethasone, and desonide etc.

Related Posts

IPC releases draft NFI-2026 to promote rational use of medicines

Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket